Article Text

Download PDFPDF

Antidepressants increase risk of behavioural symptoms in children and adolescents with depression or anxiety
Free

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Question

Question: In children and adolescents with mood or anxiety disorders, is antidepressant use associated with symptoms of excessive emotional arousal or behavioural activation?

Outcomes: Observed symptoms of excessive emotional arousal or behavioural activation, in addition to mania-hypomania (details of scales and methods not provided).

Methods

Design: Systematic review with meta-analysis.

Data sources: MEDLINE, PsycINFO, CINAHL, PubMed, Cochrane Library and Web of Science were searched from inception to March 2012, supplemented by hand search of reference lists.

Study selection and analysis: Randomised controlled trials (RCTs), retrospective studies, reviews and meta-analyses of antidepressant use in children or adolescents (aged less than 18 years) with diagnosed depression or anxiety disorders. Studies were reviewed to identify reports of the new-onset behavioural symptoms. Continuous measures were compared using analysis of variance methods or paired t tests and random-effects meta-analysis.

Main results

Forty-two studies (n=6767) met inclusion criteria. Depression: 17 studies (six RCTs) were in children/adolescents (mean age 12.5 years; 54.3% boys) with depression disorders (n=2637; 2083 taking antidepressants and …

View Full Text

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Footnotes

  • Sources of funding Bruce J Anderson Foundation; McClean Private Donors Psychopharmacology Research Fund.